|
|
Clinical validation of at-home methods of sleep assessment in Rett Syndrome |
| 5R21TR003942-02 |
|
NCATS |
2022 |
|
|
Identification and Verification of S-Nitrosylated Proteins in Bodily Fluids as Biomarkers for Parkinson's Disease and Lewy Body Dementia |
| 1 R03 TR003402-01A1 |
NAIRN, ANGUS C |
NCATS |
2021 |
|
|
A Scalable Model for Promoting Functioning and Well-Being among Older Adults with Mild Cognitive Impairment via Meaningful Social Interactions: Project SPEAK! |
| 1 R43 TR003959-01 |
PICKLE, NATHANIEL |
NCATS |
2021 |
|
|
Disability, diversity and trust in precision medicine research: stakeholdersengagement |
| 5 R01 HG010868-03 |
|
NHGRI |
2021 |
|
|
Feasibility of an Innovative Method to Understand the Dynamics of Choice and Create Diversity in Genomics Research among Older African Americans |
| 1 R21 HG011503-01 |
PASSMORE, SUSAN RACINE |
NHGRI |
2020 |
|
|
IDENTIFYING SELECTIVE USP16 INHIBITORS TO SUSTAIN STEM CELL PROLIFERATION |
| 1ZIATR000324-03 |
SIMEONOV, ANTON |
NCATS |
2019 |
|
|
OREGON CLINICAL AND TRANSLATIONAL RESEARCH INSTITUTE KL2 SUPPLEMENT |
| 3KL2TR002370-03S1 |
JACOBY, DAVID B |
NCATS |
2019 |
|
|
COMMERCIALIZATION OF A SOFTWARE PLATFORM TO INCREASE THE EFFICIENCY OF HUMAN CLINICAL TRIALS USING PATIENT-LEVEL MACHINE LEARNING MODELS |
| 5R44TR002047-03 |
ENNIST, DAVID L |
NCATS |
2019 |
|
|
IDENTIFYING SELECTIVE USP16 INHIBITORS TO SUSTAIN STEM CELL PROLIFERATION |
| 1ZIATR000324-02 |
SIMEONOV, ANTON |
NCATS |
2018 |
|
|
COMMERCIALIZATION OF A SOFTWARE PLATFORM TO INCREASE THE EFFICIENCY OF HUMAN CLINICAL TRIALS USING PATIENT-LEVEL MACHINE LEARNING MODELS |
| 2R44TR002047-02 |
ENNIST, DAVID L |
NCATS |
2018 |
